Downloads
Revenue

Description

VisuDoc è un'app per la gestione dei casi oftalmici sviluppata da VisuScience. Funziona con l'adattatore per imaging oculare per smartphone QuikVue e la fotocamera per imaging delle ghiandole di Meibomio MeiboVue. QuikVue è un adattatore per smartphone per acquisire immagini del segmento anteriore. MeiboVue è una fotocamera a infrarossi per acquisire immagini delle ghiandole di Meibomio come riferimento per la diagnosi dell'occhio secco.
VisuDoc può registrare la patologia oftalmica e le informazioni sul paziente con i pareri diagnostici del medico per la gestione della malattia.
Hide Show More...

Screenshots

VisuDoc FAQ

  • Is VisuDoc free?

    Yes, VisuDoc is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is VisuDoc legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does VisuDoc cost?

    VisuDoc is free.

  • What is VisuDoc revenue?

    To get estimated revenue of VisuDoc app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Argentina yet.
Ratings History

VisuDoc Reviews

No Reviews in Argentina
App doesn't have any reviews in Argentina yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

VisuDoc Competitors

Name
Ion Imaging
Paragon CRT® Lens Calculator
CooperVision Specialty EyeCare
PentaVision Conferences
PV Meetings
ODwire Mobile
DryEye Follow-Up
uveitisOnCall
Ophthalmology EMR & Workflow
Health Test - The iridology ap
EyeCTester Monitoring Trial
Medbase - Physicians
Patient Imaging Platform
Vision-AR-IOL

VisuDoc Installs

Last 30 days

VisuDoc Revenue

Last 30 days

VisuDoc Revenue and Downloads

Gain valuable insights into VisuDoc performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
Chinese, Portuguese, Russian, English, Spanish
Recent release
1.0.17 (2 months ago )
Released on
Feb 18, 2022 (2 years ago )
Last Updated
1 week ago